Study Stopped
No subjects enrolled
Neural Operant Conditioning
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The goal of this clinical trial is to learn if operant conditioning can reduce spasticity in order to improve walking in stroke patient. The main questions it aims to answer are:
- Can participants self-regulate reflex excitability
- Can participants self-regulate reflex, reduce spasticity and improve walking Participants will undergo surface stimulation to evoke spinal reflexes and will be asked to control these reflexes therefore reducing spasticity. Researchers will compare result to able bodied participants to see if \[insert effects\]
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Dec 2024
Longer than P75 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2023
CompletedFirst Posted
Study publicly available on registry
November 2, 2023
CompletedStudy Start
First participant enrolled
December 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2028
March 10, 2025
January 1, 2025
2.4 years
October 23, 2023
March 5, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Surface electromyographic recording of leg muscles
Recording electrical activity of leg muscles during walking in response to peripheral nerve stimulation
baseline, week 6 -mid-treatment, week 12 - end of treatment, 4-week post treatment, 12 weeks post treatment, 24 weeks post treatment
Secondary Outcomes (4)
10 meter walk test
baseline, week 6 -mid-treatment, week 12 - end of treatment, 4-week post treatment, 12 weeks post treatment, 24 weeks post treatment
quadriceps pendulum test
baseline, week 6 -mid-treatment, week 12 - end of treatment, 4-week post treatment, 12 weeks post treatment, 24 weeks post treatment
Five Times Sit to Stand Test
baseline, week 6 -mid-treatment, week 12 - end of treatment, 4-week post treatment, 12 weeks post treatment, 24 weeks post treatment
Transcranial Magnetic Stimulation (TMS)
Baseline, Week 12 - end of treatment
Study Arms (1)
Experimental: Post-stroke Stiff-Knee Gait Participants
EXPERIMENTALIndividuals with post-stroke Stiff-Knee gait
Interventions
Electrical stimulation of peripheral nerves to measure resulting gait kinematics and surface muscle activity
Eligibility Criteria
You may qualify if:
- Sign and date consent form
- At least 3 months since stroke event
- Over 18 years of age at time of eligibility
- Ability to stand upright and walk for at least 5 minutes
- Premorbidly independent
- Mild to moderate gait impairment
- Reduced knee flexion during walking relative to the unimpaired side
- Unilateral hemiparesis of the lower limbs
- Ability to evoke muscle responses through peripheral nerve stimulation, spinal cord stimulation, and transcranial magnetic stimulation
- Medically stable
- Skin intact on hemiparetic leg, abdomen, and scalp
- Ability to evoke muscle responses and/or reflex responses through peripheral nerve stimulation, spinal cord stimulation, and/or transcranial magnetic stimulation
You may not qualify if:
- Co-existing neurological condition other than prior stroke involving the hemiparetic lower limb (e.g., peripheral nerve injury, PD, SCI, TBI, MS).
- History of lower limb musculoskeletal injury
- Functionally relevant osteoarthritis and weight bearing restriction
- Functionally relevant polyneuropathy resulting in lack of sensation in the lower leg
- Functionally relevant cognitive impairment
- Functionally relevant vision impairment
- Pregnant
- Botox injection to the ipsilateral leg in the last 12 weeks or taking oral anti-spasticity medications
- Taking part in physical therapy for any walking-related impairment
- Cardiac pacemaker or other implanted electronic systems
- Uncontrolled seizure disorder
- Use of seizure lowering threshold medications and the discretion of the study physician
- Deficits in communication that interfere with reasonable study participation
- Severely impaired cognition and communication
- Severe lower limb pain
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MetroHealth Medical Center
Cleveland, Ohio, 44109, United States
Related Publications (11)
Burpee JL, Lewek MD. Biomechanical gait characteristics of naturally occurring unsuccessful foot clearance during swing in individuals with chronic stroke. Clin Biomech (Bristol). 2015 Dec;30(10):1102-7. doi: 10.1016/j.clinbiomech.2015.08.018. Epub 2015 Sep 2.
PMID: 26371855BACKGROUNDAkbas T, Kim K, Doyle K, Manella K, Lee R, Spicer P, Knikou M, Sulzer J. Rectus femoris hyperreflexia contributes to Stiff-Knee gait after stroke. J Neuroeng Rehabil. 2020 Aug 26;17(1):117. doi: 10.1186/s12984-020-00724-z.
PMID: 32843057BACKGROUNDLi S, Francisco GE. New insights into the pathophysiology of post-stroke spasticity. Front Hum Neurosci. 2015 Apr 10;9:192. doi: 10.3389/fnhum.2015.00192. eCollection 2015.
PMID: 25914638BACKGROUNDLi S, Francisco GE, Zhou P. Post-stroke Hemiplegic Gait: New Perspective and Insights. Front Physiol. 2018 Aug 2;9:1021. doi: 10.3389/fphys.2018.01021. eCollection 2018.
PMID: 30127749BACKGROUNDStoquart GG, Detrembleur C, Palumbo S, Deltombe T, Lejeune TM. Effect of botulinum toxin injection in the rectus femoris on stiff-knee gait in people with stroke: a prospective observational study. Arch Phys Med Rehabil. 2008 Jan;89(1):56-61. doi: 10.1016/j.apmr.2007.08.131.
PMID: 18164331BACKGROUNDDehnadi Moghadam A, Hasanzadeh H, Dehnadi Moghadam F. Evaluation of the Effect of Intranasal Lidocaine in the Treatment of Spasticity in Patients with Traumatic Brain Injury. Anesth Pain Med. 2021 Aug 15;11(4):e115849. doi: 10.5812/aapm.115849. eCollection 2021 Aug.
PMID: 34692437BACKGROUNDNavarrete-Opazo AA, Gonzalez W, Nahuelhual P. Effectiveness of Oral Baclofen in the Treatment of Spasticity in Children and Adolescents With Cerebral Palsy. Arch Phys Med Rehabil. 2016 Apr;97(4):604-618. doi: 10.1016/j.apmr.2015.08.417. Epub 2015 Aug 28.
PMID: 26321489BACKGROUNDWolpaw JR, Braitman DJ, Seegal RF. Adaptive plasticity in primate spinal stretch reflex: initial development. J Neurophysiol. 1983 Dec;50(6):1296-311. doi: 10.1152/jn.1983.50.6.1296.
PMID: 6663327BACKGROUNDWolpaw JR, Lee CL. Motoneuron response to dorsal root stimulation in anesthetized monkeys after spinal cord transection. Exp Brain Res. 1987;68(2):428-33. doi: 10.1007/BF00248809.
PMID: 3480233BACKGROUNDChen XY, Wolpaw JR. Operant conditioning of H-reflex in freely moving rats. J Neurophysiol. 1995 Jan;73(1):411-5. doi: 10.1152/jn.1995.73.1.411.
PMID: 7714584BACKGROUNDThompson AK, Chen XY, Wolpaw JR. Acquisition of a simple motor skill: task-dependent adaptation plus long-term change in the human soleus H-reflex. J Neurosci. 2009 May 6;29(18):5784-92. doi: 10.1523/JNEUROSCI.4326-08.2009.
PMID: 19420246BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
James Sulzer, PhD
MetroHealth Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- James Sulzer, PhD
Study Record Dates
First Submitted
October 23, 2023
First Posted
November 2, 2023
Study Start
December 31, 2024
Primary Completion (Estimated)
May 31, 2027
Study Completion (Estimated)
May 31, 2028
Last Updated
March 10, 2025
Record last verified: 2025-01